Cargando…
Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
Non-invasive blood-based molecule markers are evaluated as promising biomarkers these days. Here we investigated the potential of cell-free circulating DNA Integrity (cfDI) as blood-based marker for the prediction of recurrence during the follow-up of breast cancer patients within a prospective stud...
Autores principales: | Cheng, Jie, Cuk, Katarina, Heil, Jörg, Golatta, Michael, Schott, Sarah, Sohn, Christof, Schneeweiss, Andreas, Burwinkel, Barbara, Surowy, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589601/ https://www.ncbi.nlm.nih.gov/pubmed/28903362 http://dx.doi.org/10.18632/oncotarget.17384 |
Ejemplares similares
-
Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals
por: Cao, Xue, et al.
Publicado: (2018) -
Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
por: Cuk, Katarina, et al.
Publicado: (2013) -
DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA
por: Tang, Qiuqiong, et al.
Publicado: (2016) -
Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
por: Madhavan, Dharanija, et al.
Publicado: (2013) -
Capture and Amplification by Tailing and Switching (CATS): An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA
por: Turchinovich, Andrey, et al.
Publicado: (2014)